Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-07 | New | $11,084,569 | $11,084,569 | Other | 06b | SEC link |
| 2024-04-04 | New | $15,068,745 | $15,068,745 | Equity Only | 06b | SEC link |
| 2023-08-15 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2016-02-03 | New | $2,177,000 | $2,177,000 | Equity Only | 06b | SEC link |
| 2010-11-10 | New | $7,065,000 | $7,065,000 | Equity Only | 06 | SEC link |
| 2009-09-23 | New | $3,000,000 | Unknown | Equity Only | 06 | SEC link |
| 2008-09-02 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| David Arkowitz | Director |
| Linda Armstrong | Director |
| Marc Banjak | Executive |
| Pamela Bassett | Director |
| Martin A. Brenner | Director, Executive |
| Glenn Chang | Director |
| William Clark | Director |
| Felipe Duran | Executive |
| Arthur Elliott | Director |
| Robert Erwin | Executive |
| Seymour Flug | Director |
| Mark Giannone | Executive |
| James Hill | Director |
| Robert Kay | Executive |
| Alexandra Kropotova | Director |
| Alexandra Kroptova | Director |
| Frederick Larcombe | Executive |
| John Mc Key | Director |
| John D Mckey | Director |
| Antonio Parada | Director |
| Philip Russell | Director |
| Terence Ryan | Executive |
| Geoffrey Schild | Executive |
| Evert Schimmelpennink | Director |
| Gary Sende | Director |
| Gary Sender | Director |
| Evert Shimmelpennink | Director |